Skip to main content
Top
Published in: Journal of Clinical Immunology 1/2010

01-01-2010

Clinical Characteristics and Genotype-phenotype Correlation in 62 Patients with X-linked Agammaglobulinemia

Authors: Pamela P. W. Lee, Tong-Xin Chen, Li-Ping Jiang, Koon-Wing Chan, Wanling Yang, Bee-Wah Lee, Wen-Chin Chiang, Xiang-Yuan Chen, Susanna F. S. Fok, Tsz-Leung Lee, Marco H. K. Ho, Xi-Qiang Yang, Yu-Lung Lau

Published in: Journal of Clinical Immunology | Issue 1/2010

Login to get access

Abstract

Introduction

X-linked agammagobulinemia (XLA) is a primary immunodeficiency disorder caused by Bruton's tyrosine kinase (Btk) gene mutation. Recent studies suggested genotype-phenotype correlation in XLA, but a definitive association remains controversial.

Patients and Methods

We examined the relationship between specific Btk gene mutations and severity of clinical presentation in 62 patients with XLA. Disease severity was assessed by the age of disease onset and the presence of severe infections, while mutations were classified into severe and mild based on structural and functional consequence by bioinformatics analysis.

Results

Fifty-six Btk mutations were identified in 62 patients from 57 kindreds. Variation in phenotypes was observed, and there was a tendency of association between genotype and age of disease onset as well as occurrence of severe infections.

Conclusion

A critical analysis of the circumstances upon presentation also revealed that under-recognition of recurrent infections and relevant family history are important hurdles to timely diagnosis of XLA.
Literature
1.
go back to reference Conley ME, Dobbs AK, Farmer DM, Kilic S, Paris K, Grigoriadou S, et al. Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol. 2009;27:199–227.CrossRefPubMed Conley ME, Dobbs AK, Farmer DM, Kilic S, Paris K, Grigoriadou S, et al. Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol. 2009;27:199–227.CrossRefPubMed
2.
go back to reference Vetrie D, Vorechovský I, Sideras P, Holland J, Davies A, Flinter F, et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature. 1993;361:226–33.CrossRefPubMed Vetrie D, Vorechovský I, Sideras P, Holland J, Davies A, Flinter F, et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature. 1993;361:226–33.CrossRefPubMed
3.
go back to reference Lederman HM, Winkelstein JA. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine. 1985;64:145–56.CrossRefPubMed Lederman HM, Winkelstein JA. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine. 1985;64:145–56.CrossRefPubMed
4.
go back to reference Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med. 1993;86:31–42.PubMed Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med. 1993;86:31–42.PubMed
5.
go back to reference Conley ME, Howard V. Clinical findings leading to the diagnosis of X-linked agammaglobulinemia. J Pediatr. 2002;141:566–71.CrossRefPubMed Conley ME, Howard V. Clinical findings leading to the diagnosis of X-linked agammaglobulinemia. J Pediatr. 2002;141:566–71.CrossRefPubMed
6.
go back to reference Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, et al. X-linked agammaglobulinemia: report on a United States Registry of 201 patients. Medicine. 2006;85:193–202.CrossRefPubMed Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, et al. X-linked agammaglobulinemia: report on a United States Registry of 201 patients. Medicine. 2006;85:193–202.CrossRefPubMed
7.
go back to reference Plebani A, Soresina A, Rondelli R, Amato GM, Azzari C, Cardinale F, et al. Clinical, immunological and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: An Italian multicenter study. Clin Immunol. 2002;104:221–30.CrossRefPubMed Plebani A, Soresina A, Rondelli R, Amato GM, Azzari C, Cardinale F, et al. Clinical, immunological and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: An Italian multicenter study. Clin Immunol. 2002;104:221–30.CrossRefPubMed
8.
go back to reference López-Granados E, Pérez de Diego R, Ferreira Cerdán A, Fontán Casariego G, García Rodríguez MC. A genotype-phenotype correlation study in a group of 54 patients with X-linked agammaglobulinemia. J Allergy Clin Immunol. 2005;116:690–7.CrossRefPubMed López-Granados E, Pérez de Diego R, Ferreira Cerdán A, Fontán Casariego G, García Rodríguez MC. A genotype-phenotype correlation study in a group of 54 patients with X-linked agammaglobulinemia. J Allergy Clin Immunol. 2005;116:690–7.CrossRefPubMed
9.
go back to reference Broides A, Yang W, Conley ME. Genotype/phenotype correlations in X-linked agammaglobulinemia. Clin Immunol. 2006;118:195–200.CrossRefPubMed Broides A, Yang W, Conley ME. Genotype/phenotype correlations in X-linked agammaglobulinemia. Clin Immunol. 2006;118:195–200.CrossRefPubMed
10.
go back to reference Holinski-Feder E, Weiss M, Brandau O, Jedele KB, Nore B, Bäckesjö CM, et al. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course. Pediatrics. 1998;101:276–84.CrossRefPubMed Holinski-Feder E, Weiss M, Brandau O, Jedele KB, Nore B, Bäckesjö CM, et al. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course. Pediatrics. 1998;101:276–84.CrossRefPubMed
11.
go back to reference Casanova JL, Abel L. Primary immunodeficiencies: a field in its infancy. Science. 2007;317:617–9.CrossRefPubMed Casanova JL, Abel L. Primary immunodeficiencies: a field in its infancy. Science. 2007;317:617–9.CrossRefPubMed
12.
go back to reference Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93:190–7.CrossRefPubMed Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93:190–7.CrossRefPubMed
13.
go back to reference Yip KL, Chan SY, Ip WK, Lau YL. Bruton’s tyrosine kinase mutations in 8 Chinese families with X-linked agammaglobulinemia. Hum Mutat. 2000;15:385.CrossRefPubMed Yip KL, Chan SY, Ip WK, Lau YL. Bruton’s tyrosine kinase mutations in 8 Chinese families with X-linked agammaglobulinemia. Hum Mutat. 2000;15:385.CrossRefPubMed
14.
go back to reference Chan KW, Chen T, Jiang L, Fok SF, Lee TL, Lee BW, et al. Identification of Bruton tyrosine kinase mutations in 12 Chinese patients with X-linked agammaglobulinaemia by long PCR-direct sequencing. Int J Immunogenet. 2006;33:205–9.CrossRefPubMed Chan KW, Chen T, Jiang L, Fok SF, Lee TL, Lee BW, et al. Identification of Bruton tyrosine kinase mutations in 12 Chinese patients with X-linked agammaglobulinaemia by long PCR-direct sequencing. Int J Immunogenet. 2006;33:205–9.CrossRefPubMed
15.
go back to reference Conley ME, Broides A, Hernandez-Trujillo V, Howard V, Kanegane H, Miyawaki T, et al. Genetic analysis of patients with defects in early B-cell development. Immunol Rev. 2005;203:216–34.CrossRefPubMed Conley ME, Broides A, Hernandez-Trujillo V, Howard V, Kanegane H, Miyawaki T, et al. Genetic analysis of patients with defects in early B-cell development. Immunol Rev. 2005;203:216–34.CrossRefPubMed
16.
go back to reference Väliaho J, Smith CI, Vihinen M. BTKbase: the mutation database for X-linked agammaglobulinemia. Hum Mutat. 2006;27:1209–17. BTKbase: mutation registry for X-linked agammaglobulinemia (XLA), version 8.5 (last updated 21 August, 2008). Available from http://bioinf.uta.fi/BTKbase.CrossRefPubMed Väliaho J, Smith CI, Vihinen M. BTKbase: the mutation database for X-linked agammaglobulinemia. Hum Mutat. 2006;27:1209–17. BTKbase: mutation registry for X-linked agammaglobulinemia (XLA), version 8.5 (last updated 21 August, 2008). Available from http://​bioinf.​uta.​fi/​BTKbase.CrossRefPubMed
17.
go back to reference Mattsson PT, Vihinen M, Smith CI. X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease. Bioessays. 1996;18:825–34.CrossRefPubMed Mattsson PT, Vihinen M, Smith CI. X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease. Bioessays. 1996;18:825–34.CrossRefPubMed
21.
go back to reference Kojima T, Fukuda M, Watanabe Y, Hamazato F, Mikoshiba K. Characterization of the pleckstrin homology domain of Btk as an inositol polyphosphate and phosphoinositide binding domain. Biochem Biophys Res Commun. 1997;236:333–9.CrossRefPubMed Kojima T, Fukuda M, Watanabe Y, Hamazato F, Mikoshiba K. Characterization of the pleckstrin homology domain of Btk as an inositol polyphosphate and phosphoinositide binding domain. Biochem Biophys Res Commun. 1997;236:333–9.CrossRefPubMed
22.
go back to reference Hanks SK. Genomic analysis of the eukaryotic protein kinase superfamily: a perspective. Genome Biol. 2003;4:111.CrossRefPubMed Hanks SK. Genomic analysis of the eukaryotic protein kinase superfamily: a perspective. Genome Biol. 2003;4:111.CrossRefPubMed
23.
go back to reference Shen B, Vihinen M. Conservation and covariance in PH domain sequences: physicochemical profile and information theoretical analysis of XLA-causing mutations in the Btk PH domain. Protein Eng Des Sel. 2004;17:267–76.CrossRefPubMed Shen B, Vihinen M. Conservation and covariance in PH domain sequences: physicochemical profile and information theoretical analysis of XLA-causing mutations in the Btk PH domain. Protein Eng Des Sel. 2004;17:267–76.CrossRefPubMed
24.
go back to reference Baraldi E, Djinovic Carugo K, Hyvönen M. Structure of the PH domain from Bruton's tyrosine kinase in complex with inositol 1,3,4,5-tetrakisphosphate. Structure. 1999;7:449–60.CrossRefPubMed Baraldi E, Djinovic Carugo K, Hyvönen M. Structure of the PH domain from Bruton's tyrosine kinase in complex with inositol 1,3,4,5-tetrakisphosphate. Structure. 1999;7:449–60.CrossRefPubMed
25.
go back to reference Lindvall JM, Blomberg KE, Väliaho J, Vargas L, Heinonen JE, Berglöf A, et al. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling. Immunol Rev. 2005;203:200–15.CrossRefPubMed Lindvall JM, Blomberg KE, Väliaho J, Vargas L, Heinonen JE, Berglöf A, et al. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling. Immunol Rev. 2005;203:200–15.CrossRefPubMed
26.
go back to reference Rawlings DJ, Saffran DC, Tsukada S, et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science. 1993;261:358–61.CrossRefPubMed Rawlings DJ, Saffran DC, Tsukada S, et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science. 1993;261:358–61.CrossRefPubMed
27.
go back to reference Lappalainen I, Thusberg J, Shen B, Vihinen M. Genome wide analysis of pathogenic SH2 domain mutations. Proteins. 2008;72:779–92.CrossRefPubMed Lappalainen I, Thusberg J, Shen B, Vihinen M. Genome wide analysis of pathogenic SH2 domain mutations. Proteins. 2008;72:779–92.CrossRefPubMed
28.
go back to reference Wang Y, Kanegane H, Wang X, Han X, Zhang Q, Zhao S, et al. Mutation of the BTK gene and clinical features of X-linked agammaglobulinemia in mainland China. J Clin Immunol. 2009;29:352–6.CrossRefPubMed Wang Y, Kanegane H, Wang X, Han X, Zhang Q, Zhao S, et al. Mutation of the BTK gene and clinical features of X-linked agammaglobulinemia in mainland China. J Clin Immunol. 2009;29:352–6.CrossRefPubMed
29.
go back to reference He J, Zhao S, Jiang Z. Clinical features of 17 cases of X-linked agammaglobulinemia. Chin J Contemp Pediatr. 2008;10:139–42. He J, Zhao S, Jiang Z. Clinical features of 17 cases of X-linked agammaglobulinemia. Chin J Contemp Pediatr. 2008;10:139–42.
30.
go back to reference Chun JK, Lee TJ, Song JW, Linton JA, Kim DS. Analysis of clinical presentations of Bruton disease: a review of 20 years of accumulated data from pediatric patients at Severance Hospital. Yonsei Med J. 2008;49:28–36.CrossRefPubMed Chun JK, Lee TJ, Song JW, Linton JA, Kim DS. Analysis of clinical presentations of Bruton disease: a review of 20 years of accumulated data from pediatric patients at Severance Hospital. Yonsei Med J. 2008;49:28–36.CrossRefPubMed
31.
go back to reference Kanavaros P, Rontogianni D, Hrissovergi D, Efthimiadoy A, Argyrakos T, Mastoris K, et al. Extranodal cytotoxic T-cell lymphoma in a patient with X-linked agammaglobulinaemia. Leuk Lymphoma. 2001;42:235–8.CrossRefPubMed Kanavaros P, Rontogianni D, Hrissovergi D, Efthimiadoy A, Argyrakos T, Mastoris K, et al. Extranodal cytotoxic T-cell lymphoma in a patient with X-linked agammaglobulinaemia. Leuk Lymphoma. 2001;42:235–8.CrossRefPubMed
Metadata
Title
Clinical Characteristics and Genotype-phenotype Correlation in 62 Patients with X-linked Agammaglobulinemia
Authors
Pamela P. W. Lee
Tong-Xin Chen
Li-Ping Jiang
Koon-Wing Chan
Wanling Yang
Bee-Wah Lee
Wen-Chin Chiang
Xiang-Yuan Chen
Susanna F. S. Fok
Tsz-Leung Lee
Marco H. K. Ho
Xi-Qiang Yang
Yu-Lung Lau
Publication date
01-01-2010
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 1/2010
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-009-9341-5

Other articles of this Issue 1/2010

Journal of Clinical Immunology 1/2010 Go to the issue